Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;17(2):286-90.
doi: 10.1128/CVI.00454-09. Epub 2009 Dec 23.

Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever

Affiliations

Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever

Peter M Schneeberger et al. Clin Vaccine Immunol. 2010 Feb.

Abstract

The world's largest Q fever outbreak is ongoing in The Netherlands with around 3,000 confirmed cases since the first half of 2007. Increased awareness has resulted in early referral of patients for diagnostics. An important drawback to serological diagnosis of acute Q fever is the lag phase in antibody response. Therefore, we evaluated the performance of a real-time PCR for detection of Coxiella burnetii DNA using serum samples from patients with acute Q fever. PCR, targeting IS1111, was retrospectively performed on acute-phase and follow-up convalescent-phase serum samples from 65 patients with acute Q fever as diagnosed by immunofluorescence assay. The results obtained by PCR were related to disease stage as defined by subsequent appearance of phase II IgM, phase II IgG, phase I IgM, and phase I IgG (IgM-II, IgG-II, IgM-I, and IgG-I, respectively) antibodies and time since onset of disease. In addition, we analyzed seronegative acute-phase serum samples from patients with inconclusive Q fever serology, because no convalescent-phase serum samples were available. PCR was scored positive in 49/50 (98%) seronegative sera, 9/10 (90%) sera with isolated IgM-II antibodies, 3/13 (23%) sera with IgM-II/IgG-II antibodies, 2/41 (5%) sera with IgM-II/IgG-II/IgM-I antibodies, 0/15 (0%) sera with IgM-II/IgG-II/IgM-I/IgG-I antibodies, and 0/1 (0%) serum sample with IgM-II/IgG-II/IgG-I antibodies. The latest time point after onset of disease in which C. burnetii DNA could be detected was at day 17. In patients with inconclusive Q fever serology, PCR was positive in 5/50 (10%) cases. We conclude that real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. C. burnetii DNA becomes undetectable in serum as the serological response develops.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Coxiella burnetii real-time PCR positivity percentages in acute-phase and follow-up convalescent-phase serum samples from 65 patients with acute Q fever. Sera were grouped according to antibody profiles as determined by immunofluorescence assay. PCR was positive in 49/50 (98%) seronegative sera, 9/10 (90%) sera with isolated IgM-II antibodies, 3/13 (23%) sera with IgM-II/IgG-II antibodies, 2/41 (5%) sera with IgM-II/IgG-II/IgM-I antibodies, 0/15 (0%) sera with IgM-II/IgG-II/IgM-I/IgG-I antibodies, and 0/1 (0%) serum with IgM-II/IgG-II/IgG-I antibodies.
FIG. 2.
FIG. 2.
Relation of CT value, number of days following onset of disease, and antibody profile in 40 acute-phase and 40 follow-up convalescent-phase serum samples from 40 patients with acute Q fever for which date of onset of disease could be retrieved from the hospital information system. Symbols reflect different antibody profiles: •, seronegative sera (n = 31); ○, sera with isolated IgM-II antibodies (n = 6); ▪, sera with IgM-II/IgG-II antibodies (n = 9); □, sera with IgM-II/IgG-II/IgM-I antibodies (n = 24); ▴, sera with IgM-II/IgG-II/IgM-I/IgG-I antibodies (n = 9); ▵, serum with IgM-II/IgG-II/IgG-I antibodies (n = 1). Undet., C. burnetii DNA was undetectable.

Similar articles

Cited by

References

    1. de Wit, N. C. J., C. P. C. de Jager, J. C. E. Meekelenkamp, M. Schoorl, A. B. Gageldonk-Lafeber, A. C. A. P. Leenders, et al. 2009. Markers of infection in inpatients and outpatiens with acute Q-fever. Clin. Chem. Lab. Med. 47:1407-1409. - PubMed
    1. Dupont, H. T., X. Thirion, and D. Raoult. 1994. Q fever serology: cutoff determination for microimmunofluorescence. Clin. Diagn. Lab. Immunol. 1:189-196. - PMC - PubMed
    1. Fournier, P. E., and D. Raoult. 2003. Comparison of PCR and serology assays for early diagnosis of acute Q fever. J. Clin. Microbiol. 41:5094-5098. - PMC - PubMed
    1. Gikas, A., D. P. Kofteridis, A. Manios, J. Pediaditis, and Y. Tselentis. 2001. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob. Agents Chemother. 45:3644-3646. - PMC - PubMed
    1. Karagiannis, I., G. Morroy, A. Rietveld, A. M. Horrevorts, M. Hamans, P. Francken, et al. 2007. Q fever outbreak in the Netherlands: a preliminary report. Euro Surveill. 12:E070809.2. - PubMed

Publication types

MeSH terms